Phase 3 Ixo-Vec Program Advances

• by Jim Gallagher, senior managing editor

• May 14, 2026

FDA Clears Nocturnal IOP Device

Balance Ophthalmics gains FDA 510(k) clearance for wireless FSYX glaucoma device

• May 26, 2026

• 2 min

Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis

• by Ting Tang, Qiwen Feng, Youran Cai, Yuying Dong, Jian Chen, Rijia Zhang, Qing Zhou

• May 22, 2026

EYP-1901 for Retinal Exudative Diseases

Updates from the clinical trial program in Wet AMD and DME

• by Ashkan M. Abbey

• May 29, 2026

• 6 min